GSK employees perform anonymous ‘180’ surveys on their bosses, and CEO Emma Walmsley isn’t exempt

GSK CEO Emma Walmsley’s $13 million salary is predicated on picking the right people to steer cutting-edge drug development for the world’s most challenging diseases.

During her eight years at the helm of the pharmaceutical group, Walmsley is starting to get the hang of how to effectively recruit and retain that talent, and when to cut loose.

“When I’ve made mistakes on people, it’s usually for cultural reasons,” Walmsley told Norges Bank Investment Management CEO Nicolai Tangen on his In Good Company podcast.